Invention Grant
- Patent Title: CCL5 inhibitors
-
Application No.: US17891991Application Date: 2022-08-19
-
Publication No.: US11628154B2Publication Date: 2023-04-18
- Inventor: Bruce Kovacs
- Applicant: LAPKO INC
- Applicant Address: US NV Las Vegas
- Assignee: LAPKO INC
- Current Assignee: LAPKO INC
- Current Assignee Address: US NV Las Vegas
- Agency: Gorman IP Law, APC
- Main IPC: A61K31/216
- IPC: A61K31/216 ; A61P17/02 ; A61K45/00
Abstract:
Compounds, pharmaceutically acceptable salts, esters, prodrugs, and pharmaceutical compositions thereof are disclosed that are useful for inhibition of the biological activity of CCL5 on mammalian cells, as well as methods of treatment for diseases involving the increased biological activity of CCL5.
Public/Granted literature
- US20220409566A1 CCL5 Inhibitors Public/Granted day:2022-12-29
Information query
